We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$109B
AUM Growth
+$10.4B
Cap. Flow
-$1.13B
Cap. Flow %
-1.03%
Top 10 Hldgs %
18.72%
Holding
8,634
New
1,446
Increased
2,646
Reduced
3,048
Closed
1,267

Sector Composition

Rank Sector Weight
1 Technology 7.41%
2 Consumer Discretionary 6.04%
3 Financials 5.89%
4 Industrials 4.61%
5 Healthcare 4.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBG
6776
PUT
DELISTED
Bill Barrett Corp
BBG
$76K ﹤0.01%
16,800
+5,100
+44% +$29.7K
SNAK
6777
DELISTED
Inventure Foods, Inc.
SNAK
$76K ﹤0.01%
17,199
+351
+2% +$2.11K
AGEN
6778
CALL
Agenus
AGEN
$329M
$75K ﹤0.01%
1,014
-137
-12% -$10.9K
MFIC icon
6779
CALL
MidCap Financial Investment
MFIC
$803M
$75K ﹤0.01%
3,833
-2,267
-37% -$42K
VHC icon
6780
CALL
VirnetX Holding Corp
VHC
$62.8M
$75K ﹤0.01%
1,630
+290
+22% +$13.3K
AVXL icon
6781
PUT
Anavex Life Sciences
AVXL
$298M
$74K ﹤0.01%
12,900
-6,000
-32% -$31K
BCLI
6782
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$74K ﹤0.01%
+1,158
New +$60.3K
SGMO
6783
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$74K ﹤0.01%
14,200
-34,400
-71% -$138K
CLMT icon
6784
PUT
Calumet Specialty Products
CLMT
$4.19B
$73K ﹤0.01%
19,100
+5,200
+37% +$20.6K
PLG
6785
Platinum Group Metals
PLG
$189M
$73K ﹤0.01%
+4,463
New +$77.6K
VSTM icon
6786
Verastem
VSTM
$596M
$73K ﹤0.01%
+2,919
New +$46.4K
NH
6787
DELISTED
NantHealth, Inc
NH
$73K ﹤0.01%
+980
New +$109K
GLBL
6788
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$73K ﹤0.01%
15,297
-33,355
-69% -$151K
OCRX
6789
DELISTED
Ocera Therapeutics, Inc.
OCRX
$73K ﹤0.01%
+55,673
New +$70.9K
LSCC icon
6790
Lattice Semiconductor
LSCC
$18.5B
$72K ﹤0.01%
+10,389
New +$73.4K
TLPH icon
6791
Talphera
TLPH
$63.8M
$72K ﹤0.01%
+1,137
New +$66.9K
AXTI icon
6792
CALL
AXT Inc
AXTI
$5.34B
$71K ﹤0.01%
+12,300
New +$76.4K
CBAY
6793
DELISTED
Cymabay Therapeutics
CBAY
$71K ﹤0.01%
+16,404
New +$47.1K
ANFI
6794
PUT
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$71K ﹤0.01%
13,300
-300
-2% -$1.67K
RBPAA
6795
DELISTED
Royal Bancshares Of Pennsylvania Inc
RBPAA
$71K ﹤0.01%
+18,243
New +$73.1K
MACK
6796
CALL
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$71K ﹤0.01%
2,936
-3,012
-51% -$75.4K
ACTG icon
6797
Acacia Research
ACTG
$448M
$70K ﹤0.01%
+12,115
New +$70.7K
LSCC icon
6798
CALL
Lattice Semiconductor
LSCC
$18.5B
$70K ﹤0.01%
+10,100
New +$71.4K
VHI icon
6799
Valhi
VHI
$459M
$70K ﹤0.01%
1,773
-2,569
-59% -$104K
LGCY
6800
PUT
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$70K ﹤0.01%
30,400
+3,700
+14% +$8.35K

Similar funds

Ken Griffin's Q1 2017 Portfolio in Review

As of Q1 2017, Ken Griffin held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin's Q1 2017 filing shows 1,446 new, 2,646 increased, 3,048 reduced and 1,267 closed positions. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M. The largest sale was Alphabet (Google) Class A, an estimated $482M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 5.7% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Ken Griffin's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
  • Ken Griffin added most to Microsoft in Q1 2017, an estimated $529M increase.
  • Ken Griffin's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
  • Ken Griffin fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
  • Ken Griffin's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
  • Ken Griffin opened 1,446 new positions and closed 1,267 in Q1 2017.
  • Ken Griffin's portfolio value rose 11% quarter-over-quarter to $109B.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.